These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31859705)

  • 1. Symptom variability over the course of the day in patients with stable COPD in Brazil: a real-world observational study.
    Cukier A; Godoy I; Costa CHD; Rubin AS; Gregorio MG; Albuquerque Neto AA; Lima MA; Pereira MC; Tanni SE; Athanazio RA; Bessa EJC; Wehrmeister FC; Lourenco CB; Menezes AMB
    J Bras Pneumol; 2020; 46(3):e20190223. PubMed ID: 31859705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Miravitlles M; Menezes A; López Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Wehrmeister FC; Surmont F; Montes de Oca M
    Respir Med; 2018 Jan; 134():62-69. PubMed ID: 29413510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.
    Miravitlles M; Worth H; Soler Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
    Respir Res; 2014 Oct; 15(1):122. PubMed ID: 25331383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study.
    Kuyucu T; Güçlü SZ; Saylan B; Demir C; Senol T; Güner S; Koyuncu E; Ozen F; Oztürk S; Cangül Z; Ağanoğlu S; Ozkaya S; Ocak SC; Akkurt H; Intepe YS; Bayrak MG; Güler T; Bekçi TT; Soyyiğit S; Seyfettin S; Kula O; Akbay MO; Büyükgöze B; Asal G; Başlilar S; Oztürk O;
    Tuberk Toraks; 2011; 59(4):328-39. PubMed ID: 22233302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variability of respiratory symptoms and associated factors in COPD.
    Miravitlles M; Izquierdo JL; Esquinas C; Pérez M; Calle M; López-Campos JL; Rodríguez González-Moro JM; Casanova C; Esteban C; de Lucas P
    Respir Med; 2017 Aug; 129():165-172. PubMed ID: 28732827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD.
    Muñoz A; Small M; Wood R; Ribera A; Nuevo J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1557-1568. PubMed ID: 29805254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa.
    Kokturk N; Abuharbid W; Albanna AS; Gunen H; Gurgun A; Khadadah M; Malvolti E; Soliman M; van Zyl-Smit R; Zidouni N; Alzaabi A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2959-2970. PubMed ID: 31908444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
    Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
    Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study.
    Mihaltan F; Adir Y; Antczak A; Porpodis K; Radulovic V; Pires N; de Vries GJ; Horner A; De Bontridder S; Chen Y; Shavit A; Alecu S; Adamek L
    Respir Res; 2019 May; 20(1):89. PubMed ID: 31088560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG.
    Tsiligianni I; Metting E; van der Molen T; Chavannes N; Kocks J
    NPJ Prim Care Respir Med; 2016 Jul; 26():16040. PubMed ID: 27442618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease.
    Chang CH; Chuang LP; Lin SW; Lee CS; Tsai YH; Wei YF; Cheng SL; Hsu JY; Kuo PH; Yu CJ; Chen NH
    BMC Pulm Med; 2016 Aug; 16(1):118. PubMed ID: 27501837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS).
    Miravitlles M; Worth H; Soler-Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
    COPD; 2016 Oct; 13(5):561-8. PubMed ID: 26983349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study.
    Huang WC; Wu MF; Chen HC; Hsu JY;
    PLoS One; 2018; 13(3):e0193880. PubMed ID: 29529075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of control of patients with chronic obstructive pulmonary disease in Spain: SINCON study.
    Baloira A; Gonzalez-Moro JMR; Sanjuán E; Trigueros JA; Casamor R
    BMC Pulm Med; 2018 Dec; 18(1):183. PubMed ID: 30509238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom variability in patients with severe COPD: a pan-European cross-sectional study.
    Kessler R; Partridge MR; Miravitlles M; Cazzola M; Vogelmeier C; Leynaud D; Ostinelli J
    Eur Respir J; 2011 Feb; 37(2):264-72. PubMed ID: 21115606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN; Yu WC; Wong CK; Lam MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD.
    Ding B; Small M; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():589-599. PubMed ID: 28243077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.